NCT06944236View on ClinicalTrials.gov

CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Metabolic SyndromeCardiovascular DiseasesChronic Kidney Disease(CKD)
Interventions
OTHER

No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.

No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.

Trial Locations (1)

27900

Bağlarbaşı Family Health Center, Gaziantep

All Listed Sponsors
lead

University of Gaziantep

OTHER